BUFFALO, N.Y. – Researchers have shown for the first time that intermittent fasting increases the efficacy of anti-androgen therapy in prostate cancer, according to a paper reporting preclinical ...
Prostate cancer is the most common cancer among men after skin cancer, with approximately 1 in 8 men diagnosed in their ...
Scientists based in Australia and China have identified a pair of pesky enzymes responsible for prolonging prostate cancer – ...
Prostate cancer is the most common form of cancer in the UK, according to Prostate Cancer UK. Cancer Research UK says ...
PSA testing and digital rectal exams are crucial for early detection of prostate cancer, enabling timely intervention and improved outcomes. Treatment options include active surveillance, surgery, ...
Former President Joe Biden, who was diagnosed with an aggressive form of prostate cancer in May, completed a course of ...
This comprehensive guide provides essential information to help patients and their families navigate their prostate cancer journey. Prostate cancer is a malignant tumor that develops in the prostate ...
LOS ANGELES, July 09, 2025 (GLOBE NEWSWIRE) -- Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer and autoimmune diseases, ...
Researchers have shown for the first time that intermittent fasting increases the efficacy of anti-androgen therapy in prostate cancer, according to a paper reporting preclinical results published Aug ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback